Adverse health consequences in COPD patients with rapid decline in FEV1--evidence from the UPLIFT trial.
Kesten S, Celli B, Decramer M, Liu D, Tashkin D. Adverse health consequences in COPD patients with rapid decline in FEV1--evidence from the UPLIFT trial. Respir Res. 2011 Sep 28; 12:129.